Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
about
Alpha4 integrins and the immune responseTargeting leukocyte integrins in human diseasesNovel therapy for asthma.Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo.Natalizumab for the treatment of multiple sclerosis and Crohn's disease.Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast cancer.An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis.Biomedical insights into cell adhesion and migration-from a viewpoint of central nervous system tumor immunology.Functionalized liposome purification via Liposome Extruder Purification (LEP).Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.Mechanisms of leucocyte recruitment to the inflamed large intestine: redundancy in integrin and addressin usage.Efficacy of IL-13 neutralization in a sheep model of experimental asthma.Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13.Airway remodelling in asthma
P2860
Q28202046-F42EFDB4-5934-4941-9031-6883B4E3286BQ28293910-A2F87886-1FF3-42F2-AB56-FCA314F84CDCQ34074657-FAC7E8C5-6B1D-47FD-8113-87E414C7C3B6Q35189921-318C1094-BE94-4CE6-8068-A45113C890FFQ35941557-CD5D3491-7E72-4837-9863-A16601D72C10Q36284072-7B0C6978-1CEE-46BA-B9D3-B5974070A6F6Q39102273-586DF756-EFB9-49E4-898F-C1CDC5151530Q42637668-D9E31A63-7610-4A87-9DCD-AAFA686DEED9Q43223622-E00875EE-6ADC-4E41-83B9-35A86F054C55Q46304429-31F07BC5-9AC5-4718-A375-383048566500Q46667235-0F5D1755-0EE2-48F4-8D1B-B9963F7EA5DDQ46770599-70F5A9D8-91B1-4665-8619-05ADE1556FAEQ48084266-19D4BDBA-876D-495F-A66D-5E0659E5C294Q48355456-36B79747-576D-4E7B-ACFE-5E1ABA60BEDEQ57786263-9A868A67-8C10-448D-8681-C3EF0D7DEAD7
P2860
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
@ast
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
@en
type
label
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
@ast
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
@en
prefLabel
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
@ast
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
@en
P1476
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
@en
P2093
P304
P356
10.1016/S1367-5931(98)80120-8
P577
1998-08-01T00:00:00Z